SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8805I recall looking at the Xopenex use patents a few years ago - looked reasonable Biomaven-9/8/2005
8804Breath Ltd. is a respiratory and sterile drug subsidiary of Arrow Group (do not Robohogs-9/7/2005
8803Typo: in the first citation, <i>Breath Ltd</i> is item 10 (not item DewDiligence_on_SI-9/7/2005
8802Some <i>Breath Ltd</i> citations: ALBUTEROL SULFATE INHALATION SOLUDewDiligence_on_SI-9/7/2005
8801if it is not on google, it doesn't exist ;-)Iamarangerboy-9/7/2005
8800Who is Breath ltd? A short hedge fund? JonRobohogs-9/7/2005
8799Sepracor Receives Notice of Abbreviated New Drug Application Submission for LevaIcebrg-9/7/2005
8798Xopenex ANDA filed with Paragraph 4 certification. On Dow Jones now.Rocky9-9/7/2005
8797"the de-stocking does not really need to happen given the increases in saleRocky9-9/7/2005
8796....for those who believe in the technicals, as good as the last 2 days have felIamarangerboy-9/7/2005
8795Their argument is that the de-stocking does not really need to happen given the Robohogs-9/7/2005
8794Rocky, that lack of 4th quarter follow through is really odd... even if NRx flatHarold Engstrom-9/7/2005
8793"What takes the analysts so long to add up the script numbers and note the Rocky9-9/7/2005
8792$81m Q3 estimate for L? That would put run rate at about $400m+ at end of quartHarold Engstrom-9/7/2005
8791Whatever happened to saying something is a layup??? Not all of us can slam it ekenhott-9/7/2005
8790ML and Lehman reiterate the JPM message. Of more interest, Piper, Lehman and WeRobohogs-9/7/2005
8789Suntrust, Lehman and Merrill out with reports on CR approval. Suntrust basicallRobohogs-9/7/2005
8788Trends continued into late August as expected - numbers were just off my estimatRobohogs-9/7/2005
8787Jon, thanks for all the probing (if not mining(-:)). I guess CR's mixed bagquidditch-9/7/2005
8786Launch comparisons: I have gone back into some old scrip reports to compare somRobohogs-9/7/2005
8785I will get to scrip data in one second but first, parsing the label from JPM. TRobohogs-9/7/2005
8784Jon, any avail info on last weeks scrips? How will the holiday weekend effect thIamarangerboy-9/6/2005
8783<i>I am disappointed though as sources indicated that it would not get theDewDiligence_on_SI-9/6/2005
8782I don't see blanket implications to other sepr patents. I don't recallrkrw-9/6/2005
8781Sell the rumor and buy the news. I am disappointed though as sources indicated Robohogs-9/6/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News